Growth Metrics

Organogenesis Holdings (ORGO) Retained Earnings (2016 - 2025)

Historic Retained Earnings for Organogenesis Holdings (ORGO) over the last 10 years, with Q3 2025 value amounting to -$46.8 million.

  • Organogenesis Holdings' Retained Earnings rose 210.33% to -$46.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$46.8 million, marking a year-over-year increase of 210.33%. This contributed to the annual value of -$40.1 million for FY2024, which is 210.15% up from last year.
  • As of Q3 2025, Organogenesis Holdings' Retained Earnings stood at -$46.8 million, which was up 210.33% from -$68.3 million recorded in Q2 2025.
  • Organogenesis Holdings' 5-year Retained Earnings high stood at -$40.1 million for Q4 2024, and its period low was -$140.8 million during Q1 2021.
  • For the 5-year period, Organogenesis Holdings' Retained Earnings averaged around -$62.4 million, with its median value being -$52.8 million (2022).
  • Per our database at Business Quant, Organogenesis Holdings' Retained Earnings skyrocketed by 6076.18% in 2021 and then tumbled by 3797.42% in 2024.
  • Organogenesis Holdings' Retained Earnings (Quarter) stood at -$60.8 million in 2021, then increased by 25.53% to -$45.3 million in 2022, then grew by 9.56% to -$41.0 million in 2023, then rose by 2.1% to -$40.1 million in 2024, then decreased by 16.62% to -$46.8 million in 2025.
  • Its Retained Earnings stands at -$46.8 million for Q3 2025, versus -$68.3 million for Q2 2025 and -$59.0 million for Q1 2025.